Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Pharmaceuticals - Scandinavia Industry Guide

Published by: Datamonitor

Published: Aug. 1, 2009 - 95 Pages


Table of Contents


CHAPTER 1 INTRODUCTION
1.1 What is this report about?
1.2 Who is the target reader?
1.3 How to use this report
1.4 Definitions
CHAPTER 2 SCANDINAVIA PHARMACEUTICALS INDUSTRY OUTLOOK
2.1 Market Analysis
2.2 Market Revenues
2.3 Market Segmentation
CHAPTER 3 PHARMACEUTICALS IN DENMARK
3.1 Market Overview
3.2 Market Value
3.3 Market Segmentation I
3.4 Market Segmentation II
3.5 Market Share
3.6 Five Forces Analysis
3.7 Leading Companies
3.8 Market Forecasts
3.9 Macroeconomic Indicators
CHAPTER 4 PHARMACEUTICALS IN NORWAY
4.1 Market Overview
4.2 Market Value
4.3 Market Segmentation I
4.4 Market Segmentation II
4.5 Market Share
4.6 Five Forces Analysis
4.7 Leading Companies
4.8 Market Forecasts
4.9 Macroeconomic Indicators
CHAPTER 5 PHARMACEUTICALS IN SWEDEN
5.1 Market Overview
5.2 Market Value
5.3 Market Segmentation I
5.4 Market Segmentation II
5.5 Market Share
5.6 Five Forces Analysis
5.7 Leading Companies
5.8 Market Forecasts
5.9 Macroeconomic Indicators
CHAPTER 6 APPENDIX
6.1 Data Research Methodology
LIST OF TABLES
Table 1: Scandinavia Pharmaceuticals industry, revenue ($ bn) 2004-2013
Table 2: Scandinavia Pharmaceuticals industry, revenue ($ bn) 2004-2008(e)
Table 3: Scandinavia Pharmaceuticals industry forecast, revenue ($ bn) 2008-2013
Table 4: Denmark Pharmaceuticals Market Value: $ billion, 2004-2008
Table 5: Denmark Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 6: Denmark Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 7: Denmark Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Table 8: Key Facts: Pfizer Inc
Table 9: Key Financials: Pfizer Inc
Table 10: Key Facts: Orifarm A/S
Table 11: Key Facts: Nycomed International Management GmbH
Table 12: Key Financials: Nycomed International Management GmbH
Table 13: Key Facts: GlaxoSmithKline Plc
Table 14: Key Financials: GlaxoSmithKline Plc
Table 15: Denmark Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 16: Denmark Size of Population (million), 2004-2008
Table 17: Denmark GDP (Constant 2000 Prices, $ billion), 2004-2008
Table 18: Denmark Inflation, 2004-2008
Table 19: Denmark Exchange Rate, 2004-2008
Table 20: Norway Pharmaceuticals Market Value: $ billion, 2004-2008
Table 21: Norway Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 22: Norway Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 23: Norway Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Table 24: Key Facts: Pfizer Inc
Table 25: Key Financials: Pfizer Inc
Table 26: Key Facts: GlaxoSmithKline Plc
Table 27: Key Financials: GlaxoSmithKline Plc
Table 28: Key Facts: AstraZeneca PLC
Table 29: Key Financials: AstraZeneca PLC
Table 30: Norway Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 31: Norway Size of Population (million), 2004-2008
Table 32: Norway GDP (Constant 2000 Prices, $ billion), 2004-2008
Table 33: Norway Inflation, 2004-2008
Table 34: Norway Exchange Rate, 2004-2008
Table 35: Sweden Pharmaceuticals Market Value: $ billion, 2004-2008
Table 36: Sweden Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 37: Sweden Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 38: Sweden Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Table 39: Key Facts: Pfizer Inc
Table 40: Key Financials: Pfizer Inc
Table 41: Key Facts: AstraZeneca PLC
Table 42: Key Financials: AstraZeneca PLC
Table 43: Key Facts: Novartis AG
Table 44: Key Financials: Novartis AG
Table 45: Sweden Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 46: Sweden Size of Population (million), 2004-2008
Table 47: Sweden GDP (Constant 2000 Prices, $ billion), 2004-2008
Table 48: Sweden Inflation, 2004-2008
Table 49: Sweden Exchange Rate, 2004-2008
LIST OF FIGURES
Figure 1: Scandinavia Pharmaceuticals industry, revenue ($ bn) 2004-2013
Figure 2: Scandinavia Pharmaceuticals industry, revenue ($ bn) 2004-2008(e)
Figure 3: Scandinavia Pharmaceuticals industry forecast, revenue ($ bn) 2008-2013
Figure 4: Scandinavia Pharmaceuticals industry, Segmentation (%) 2008
Figure 5: Denmark Pharmaceuticals Market Value: $ billion, 2004-2008
Figure 6: Denmark Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 7: Denmark Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 8: Denmark Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Figure 1: Forces Driving Competition in the Pharmaceuticals Market in Denmark
Figure 2: Drivers of Buyer Power in the Pharmaceuticals Market in Denmark
Figure 3: Drivers of Supplier Power in the Pharmaceuticals Market in Denmark
Figure 4: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Denmark
Figure 5: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Denmark
Figure 6: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Denmark
Figure 7: Revenues & Profitability: Pfizer Inc
Figure 8: Revenues & Profitability: Nycomed International Management GmbH
Figure 9: Revenues & Profitability: GlaxoSmithKline Plc
Figure 10: Denmark Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 11: Norway Pharmaceuticals Market Value: $ billion, 2004-2008
Figure 12: Norway Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 13: Norway Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 14: Norway Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Figure 15: Forces Driving Competition in the Pharmaceuticals Market in Norway
Figure 16: Drivers of Buyer Power in the Pharmaceuticals Market in Norway
Figure 17: Drivers of Supplier Power in the Pharmaceuticals Market in Norway
Figure 18: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Norway
Figure 19: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Norway
Figure 20: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Norway
Figure 21: Revenues & Profitability: Pfizer Inc
Figure 22: Revenues & Profitability: GlaxoSmithKline Plc
Figure 23: Revenues & Profitability: AstraZeneca PLC
Figure 24: Norway Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 25: Sweden Pharmaceuticals Market Value: $ billion, 2004-2008
Figure 26: Sweden Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 27: Sweden Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 28: Sweden Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Figure 29: Forces Driving Competition in the Pharmaceuticals Market in Sweden
Figure 30: Drivers of Buyer Power in the Pharmaceuticals Market in Sweden
Figure 31: Drivers of Supplier Power in the Pharmaceuticals Market in Sweden
Figure 32: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Sweden
Figure 33: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Sweden
Figure 34: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Sweden
Figure 35: Revenues & Profitability: Pfizer Inc
Figure 36: Revenues & Profitability: AstraZeneca PLC
Figure 37: Revenues & Profitability: Novartis AG
Figure 38: Sweden Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Abstract

Datamonitor's Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data on market value, segmentation, and five forces analysis, plus full five year market forecasts for each country. It examines future problems, innovations and potential growth areas within the market.

Scope of the Report
  • Contains an executive summary market values, and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Compares data from Denmark, Norway and Sweden, alongside individual chapters on each country. .
  • Includes a five-year forecast of the industry
Highlights

The Scandinavian Pharmaceuticals market had a total market value of $8.8 billion in 2008.

Denmark was the fastest growing country with a CAGR of 9.6% over the 2004-2008 period.

Within the Pharmaceuticals industry, Sweden is the leading country among the Scandinavian countries, with market revenues of $4.3 billion in 2008.

The Pharmaceuticals industry in Sweden is expected to lead the Scandinavian countries with a value of $5.4 billion in 2013.

Why you should buy this report
  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research
Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009